Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.665 USD | -1.42% | +3.42% | -12.53% |
04-18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
04-16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.53% | 2.09B | |
+4.33% | 106B | |
+6.75% | 23.47B | |
-14.38% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.90% | 16.78B | |
+7.30% | 14.41B | |
+38.54% | 12.86B | |
+323.75% | 8.78B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Sector Update: Health Care Stocks Climb Pre-Bell Friday